SCHEMBL19102154

SCHEMBL19102154

C=N/C(N)=C(\N=C(/C)c1ccc([S+]([O-])C(C)C)cc1)C(=N)OC(=N)CCNC(=O)OC(C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ ATR Q13535 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13138246 0.67 ATR (0.73) ATR
SCHEMBL17618321 0.58 SMN1; SMN2 (0.45) —
SCHEMBL24622110 0.57 TDP1 (0.46) —
SCHEMBL16775745 0.56 SMN1; SMN2 (0.45) —
SCHEMBL24117937 0.56 GAA (0.46) —
SCHEMBL608970 0.55 MAOA (0.60) —
SCHEMBL12089871 0.55 HPGD (0.55) —
SCHEMBL17623727 0.55 MEN1 (0.47) —
SCHEMBL21221607 0.55 MEN1 (0.43) —
SCHEMBL12564993 0.55 KDM4E (0.53) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9701674-B2 Substituted pyrazines as ATR kinase inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2017-07-11 — — US disclosed
Send feedback